Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall C & D
*Purpose: Cell-mediated immunity plays an important role in controlling human adenovirus (HAdV) infection after kidney transplantation (KT). We investigated T cell lymphocyte subsets and HAdV-specific T cell responses in KT recipients diagnosed with HAdV infection.
*Methods: We conducted a prospective study (January 2015 to June 2018). Interferon (IFN)-γ-producing CD4+ and CD8+ T cells were measured at diagnosis and at viral clearance, by an intracellular cytokine assay after stimulating with HAdV whole lysate, and hexon (HAdV-3) and penton (HAdV-5) proteins.
*Results: Eighteen adult KT recipients were diagnosed with HAdV infection at a median of 16 months (IQR, 2-39 months) after KT. The absolute lymphocyte count at viral clearance was significantly higher compared with diagnosis (2,257 cells/µL [IQR, 1,544-3078] vs. 1,001 cells/µL [IQR, 641-1,385]; p<0.001). Eleven patients underwent measurement of the HAdV-specific T cell response. The median numbers of CD4+ and CD8+ T cells at viral clearance were significantly higher compared with diagnosis (448 vs. 215 cells/µL; p=0.02 and 623 vs. 235 cells/µL; p<0.01, respectively). The median percentages of HAdV-5-specific CD4+ and HAdV-3-specific CD8+ T cells at viral clearance were significantly higher compared with diagnosis (0.012 vs. 0; p=0.03 and 0.136 vs. 0.016; p=0.003, respectively), Figure 1.
*Conclusions: Our findings suggest a trend of HAdV-specific T cell immune restoration in KT recipients who achieve successful viral clearance. Our study supports a potential role of virus-specific T cell immune monitoring to optimize management of HAdV in KT recipients.
To cite this abstract in AMA style:Bruminhent J, Apiwattanakul N, Hongeng S, Kantachuvessiri S, Watcharananan SP. Human Adenovirus-Specific T Cell Response in Kidney Transplant Recipients Diagnosed with Adenovirus Infection [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/human-adenovirus-specific-t-cell-response-in-kidney-transplant-recipients-diagnosed-with-adenovirus-infection/. Accessed January 21, 2022.
« Back to 2019 American Transplant Congress